Search

Your search keyword '"Baldridge D"' showing total 99 results

Search Constraints

Start Over You searched for: Author "Baldridge D" Remove constraint Author: "Baldridge D"
99 results on '"Baldridge D"'

Search Results

1. Mechanism of KMT5B haploinsufficiency in neurodevelopment in humans and mice.

2. De Novo and Bi-allelic Pathogenic Variants in NARS1 Cause Neurodevelopmental Delay Due to Toxic Gain-of-Function and Partial Loss-of-Function Effects

Catalog

Books, media, physical & digital resources

8. NATIVE MIGRATION: IN SEARCH OF THE MISSING COHORTS. AMERICAN INDIAN AND ALASKA NATIVE MIGRATION AND THE LOSS OF CAREGIVERS IN NATIVE COMMUNITIES.

10. Effect of N Fertilization on Sugarbeet Crown Tissue Production and Processing Quality1

11. Selection for Yield and Yield Components in Wheat1

12. Fungicide Treatment of Wheat Seed: Is it Necessary?1,2

13. Grain and Plant Nitrogen Relationships in Eight Spring Wheat Crosses, Triticum aestivumL.1

15. Registration of Winridge Wheat

19. Registration of Redwin Wheat

26. Agronomic Response of Three Height Classes of Spring Wheat, Triticum aestivumL., Compared at Different Yield Levels1

27. The Genetic Basis Of Autosomal Recessive Osteogenesis Imperfecta In The Irish Traveller Population.

30. Brain malformations and seizures by impaired chaperonin function of TRiC.

31. Loss of function of FAM177A1, a Golgi complex localized protein, causes a novel neurodevelopmental disorder.

32. The Brain Gene Registry: a data snapshot.

33. Clinical variants paired with phenotype: A rich resource for brain gene curation.

34. Dominant negative variants in KIF5B cause osteogenesis imperfecta via down regulation of mTOR signaling.

35. Macrocephaly and developmental delay caused by missense variants in RAB5C.

36. PSMC3 proteasome subunit variants are associated with neurodevelopmental delay and type I interferon production.

37. Mechanism of KMT5B haploinsufficiency in neurodevelopment in humans and mice.

38. GABBR1 monoallelic de novo variants linked to neurodevelopmental delay and epilepsy.

39. Functional analysis of a novel de novo variant in PPP5C associated with microcephaly, seizures, and developmental delay.

40. A dominant negative variant of RAB5B disrupts maturation of surfactant protein B and surfactant protein C.

41. Effect of Whole-Genome Sequencing on the Clinical Management of Acutely Ill Infants With Suspected Genetic Disease: A Randomized Clinical Trial.

42. Sex- and mutation-specific p53 gain-of-function activity in gliomagenesis.

43. Functional analysis of a de novo variant in the neurodevelopment and generalized epilepsy disease gene NBEA.

44. Altered neuronal physiology, development, and function associated with a common chromosome 15 duplication involving CHRNA7.

45. Biallelic ASCC1 variants including a novel intronic variant result in expanded phenotypic spectrum of spinal muscular atrophy with congenital bone fractures 2 (SMABF2).

46. Commonalities across computational workflows for uncovering explanatory variants in undiagnosed cases.

47. Model organisms contribute to diagnosis and discovery in the undiagnosed diseases network: current state and a future vision.

48. Discovery of a novel CHD7 CHARGE syndrome variant by integrated omics analyses.

49. De Novo and Bi-allelic Pathogenic Variants in NARS1 Cause Neurodevelopmental Delay Due to Toxic Gain-of-Function and Partial Loss-of-Function Effects.

50. Precise breakpoint detection in a patient with 9p- syndrome.